Over 80 million dollars' worth of counterfeit
pharmaceuticals were seized over a three-day period last July in
several African ports at the close of an international customs
operation. A significant portion of those drugs simply did not
contain any active ingredients. Counterfeit pharmaceuticals have
taken on industrial proportions. Counterfeiters will even go so far
as to imitate the holograms that appear on drug packaging. These
imitations, which often wind up in the official pharmaceutical
network, pose a major threat to a vulnerable population and cost
the pharmaceutical industry a tremendous amount of money.
Reform of the U.S. Patent System
The U.S. America Invents Act celebrated its anniversary on
September 16, 2012 and many important provisions affecting the U.S.
patent system went into effect that day. Additional substantial
changes will come into effect in March 2013.
Reduction of PCT Fees
A new Patent Cooperation Treaty (PCT) schedule of fees is
applicable for PCT applications filed at the Canadian receiving
office on or after September 1st, 2012. The new schedule
comprises a slight diminution (about 5%) of the International
Filing Fee and of the Handling fee.
The RAMQ's investigative powers are subject to privacy and
professional secrecy rights
The investigative powers conferred on the Régie de
l'assurance-maladie du Québec, to control fee claims
made by health professionals participating in the health insurance
plan does not include the right to obtain patients' medical
records from the professionals involved. Indeed, the provisions of
the Health Insurance Act do not permit a breach of the
patients' right to privacy nor of their right to professional
Administrative sanctions imposed to doctors practising in
hospitals must comply with an Act respecting Health Services and
Regulations relating to the use of the operating room in an
hospital are rules governing the use of medical and material
resources and therefore should be adopted by its board of directors
on recommendation of the establishment's council of physicians,
dentists and pharmacists. Otherwise, the administrative sanctions
imposed under these regulations may be declared void.
Draft Guidance Document: The Use of Foreign Reviews by Health
Canada and revisions to the Use of Foreign Reviews pilot
Health Canada recently released a draft Guidance document that is intended to
inform market authorization holders on how Health Canada uses
foreign reviews, and how they can help facilitate this use.
Effective September 1, 2016, the Disposition of Surplus Real Property Regulation to the Ontario Education Act was amended with the intention to reduce barriers to the formation of health and community hubs in Ontario.
This appeal relates to two generic drug submissions for two different products: exemestane and infliximab. Both submissions cross-referenced the submission of another generic company that had received a Notice of Compliance.
Two recent decisions from the Supreme Court of Canada directly affect Quebec's farm businesses by confirming La Financière Agricole du Québec's discretion in the administration of the farm income stabilization program...
On October 6, 2016, the Ontario Legislature reintroduced the Patients First Act, 2016 as Bill 41. Bill 41 is very similar to its predecessor, Bill 210, which was introduced in June 2016, but makes some important changes to the previous bill.
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).